Robert Thomas Freeman, Chief Financial Officer at Alignment Healthcare, Inc. (ALHC), sold 143,858 shares at $10.00 ($1.4M) on 2024-07-18, disclosed to the SEC on 2024-07-19.
Scheduled sale ($1.4M) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.00 | 22,100 | $221K | 15.4% |
| 2 | $10.00 | 44,042 | $440K | 30.6% |
| 3 | $10.01 | 38,858 | $389K | 27.0% |
| 4 | $10.01 | 38,858 | $389K | 27.0% |
| Total | $10.01 avg | 143,858 | $1.4M | 100% |
| Filing → |
| ALHC | SELL | 2025-03-13 | $450K | — | Filing → |
| ALHC | SELL | 2025-03-06 | $10.7M | — | Filing → |
| ALHC | SELL | 2024-11-13 | $409K | — | Filing → |